{"database": "openregs", "table": "documents", "rows": [["EPA-HQ-OPP-2012-0565-0054", "EPA", "EPA-HQ-OPP-2012-0565", "Norflurazon: Summary of Hazard and Science Policy Council (HASPOC) Meetings on February 7th and March 7th, 2019. Revisit of the Recommendations on the need for Comparative Thyroid Assay. (March 14, 2019)", "Supporting & Related Material", "Memorandum", "2022-12-23T05:00:00Z", 2022, 12, null, null, "2022-12-24T01:50:29Z", null, 0, 0, "0900006485547d60"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["EPA-HQ-OPP-2012-0565-0054"], "units": {}, "query_ms": 81.69997995719314, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}